Literature DB >> 32227229

SWI/SNF complex differences promote cellular heterogeneity in rhabdoid tumors.

Charles G Eberhart1,2, Jeffrey A Rubens2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32227229      PMCID： PMC7283025          DOI： 10.1093/neuonc/noaa081

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN： 1522-8517            Impact factor:   12.300


× No keyword cloud information.
  10 in total

1.  Cross-platform single cell analysis of kidney development shows stromal cells express Gdnf.

Authors:  Bliss Magella; Mike Adam; Andrew S Potter; Meenakshi Venkatasubramanian; Kashish Chetal; Stuart B Hay; Nathan Salomonis; S Steven Potter
Journal:  Dev Biol       Date:  2017-11-26       Impact factor: 3.582

2.  Clonally Expanded T Cells Reveal Immunogenicity of Rhabdoid Tumors.

Authors:  Amaury Leruste; Jimena Tosello; Rodrigo Nalio Ramos; Arnault Tauziède-Espariat; Solène Brohard; Zhi-Yan Han; Kevin Beccaria; Mamy Andrianteranagna; Pamela Caudana; Jovan Nikolic; Céline Chauvin; Leticia Laura Niborski; Valeria Manriquez; Wilfrid Richer; Julien Masliah-Planchon; Sandrine Grossetête-Lalami; Mylene Bohec; Sonia Lameiras; Sylvain Baulande; Celio Pouponnot; Aurore Coulomb; Louise Galmiche; Didier Surdez; Nicolas Servant; Julie Helft; Christine Sedlik; Stéphanie Puget; Philippe Benaroch; Olivier Delattre; Joshua J Waterfall; Eliane Piaggio; Franck Bourdeaut
Journal:  Cancer Cell       Date:  2019-11-07       Impact factor: 31.743

3.  Inhibition of MYC attenuates tumor cell self-renewal and promotes senescence in SMARCB1-deficient Group 2 atypical teratoid rhabdoid tumors to suppress tumor growth in vivo.

Authors:  Irina Alimova; Angela Pierce; Etienne Danis; Andrew Donson; Diane K Birks; Andrea Griesinger; Nicholas K Foreman; Mariarita Santi; Laura Soucek; Sujatha Venkataraman; Rajeev Vibhakar
Journal:  Int J Cancer       Date:  2019-01-10       Impact factor: 7.396

4.  Atypical Teratoid/Rhabdoid Tumors Are Comprised of Three Epigenetic Subgroups with Distinct Enhancer Landscapes.

Authors:  Pascal D Johann; Serap Erkek; Marc Zapatka; Kornelius Kerl; Ivo Buchhalter; Volker Hovestadt; David T W Jones; Dominik Sturm; Carl Hermann; Maia Segura Wang; Andrey Korshunov; Marina Rhyzova; Susanne Gröbner; Sebastian Brabetz; Lukas Chavez; Susanne Bens; Stefan Gröschel; Fabian Kratochwil; Andrea Wittmann; Laura Sieber; Christina Geörg; Stefan Wolf; Katja Beck; Florian Oyen; David Capper; Peter van Sluis; Richard Volckmann; Jan Koster; Rogier Versteeg; Andreas von Deimling; Till Milde; Olaf Witt; Andreas E Kulozik; Martin Ebinger; Tarek Shalaby; Michael Grotzer; David Sumerauer; Josef Zamecnik; Jaume Mora; Nada Jabado; Michael D Taylor; Annie Huang; Eleonora Aronica; Anna Bertoni; Bernhard Radlwimmer; Torsten Pietsch; Ulrich Schüller; Reinhard Schneppenheim; Paul A Northcott; Jan O Korbel; Reiner Siebert; Michael C Frühwald; Peter Lichter; Roland Eils; Amar Gajjar; Martin Hasselblatt; Stefan M Pfister; Marcel Kool
Journal:  Cancer Cell       Date:  2016-02-25       Impact factor: 31.743

5.  SMARCA4-mutated atypical teratoid/rhabdoid tumors are associated with inherited germline alterations and poor prognosis.

Authors:  Martin Hasselblatt; Inga Nagel; Florian Oyen; Kerstin Bartelheim; Robert B Russell; Ulrich Schüller; Reimar Junckerstorff; Marc Rosenblum; Ali H Alassiri; Sabrina Rossi; Irene Schmid; Nicholas G Gottardo; Helen Toledano; Elisabetta Viscardi; Milagros Balbin; Leora Witkowski; Qianhao Lu; Matthew J Betts; William D Foulkes; Reiner Siebert; Michael C Frühwald; Reinhard Schneppenheim
Journal:  Acta Neuropathol       Date:  2014-07-25       Impact factor: 17.088

6.  Malignant rhabdoid tumor shows a unique neural differentiation as distinct from neuroblastoma.

Authors:  Katsumi Higashino; Tsutomu Narita; Takashi Taga; Shigeru Ohta; Yoshihiro Takeuchi
Journal:  Cancer Sci       Date:  2003-01       Impact factor: 6.716

7.  SWI/SNF complex heterogeneity is related to polyphenotypic differentiation, prognosis, and immune response in rhabdoid tumors.

Authors:  Pooja Panwalkar; Drew Pratt; Chan Chung; Derek Dang; Paul Le; Daniel Martinez; Jill M Bayliss; Kyle S Smith; Mike Adam; Steven Potter; Paul A Northcott; Leo Mascarenhas; Jared Shows; Bruce Pawel; Ashley Margol; Annie Huang; Alexander R Judkins; Sriram Venneti
Journal:  Neuro Oncol       Date:  2020-06-09       Impact factor: 12.300

8.  Unbiased Metabolic Profiling Predicts Sensitivity of High MYC-Expressing Atypical Teratoid/Rhabdoid Tumors to Glutamine Inhibition with 6-Diazo-5-Oxo-L-Norleucine.

Authors:  Eric H Raabe; Jeffrey A Rubens; Sabrina Z Wang; Brad Poore; Jesse Alt; Antoinette Price; Sariah J Allen; Allison R Hanaford; Harpreet Kaur; Brent A Orr; Barbara S Slusher; Charles G Eberhart
Journal:  Clin Cancer Res       Date:  2019-07-12       Impact factor: 12.531

9.  Atypical teratoid rhabdoid tumor: improved long-term survival with an intensive multimodal therapy and delayed radiotherapy. The Medical University of Vienna Experience 1992-2012.

Authors:  Irene Slavc; Monika Chocholous; Ulrike Leiss; Christine Haberler; Andreas Peyrl; Amedeo A Azizi; Karin Dieckmann; Adelheid Woehrer; Christina Peters; Georg Widhalm; Christian Dorfer; Thomas Czech
Journal:  Cancer Med       Date:  2013-12-11       Impact factor: 4.452

10.  Integrated (epi)-Genomic Analyses Identify Subgroup-Specific Therapeutic Targets in CNS Rhabdoid Tumors.

Authors:  Jonathon Torchia; Brian Golbourn; Shengrui Feng; King Ching Ho; Patrick Sin-Chan; Alexandre Vasiljevic; Joseph D Norman; Paul Guilhamon; Livia Garzia; Natalia R Agamez; Mei Lu; Tiffany S Chan; Daniel Picard; Pasqualino de Antonellis; Dong-Anh Khuong-Quang; Aline C Planello; Constanze Zeller; Dalia Barsyte-Lovejoy; Lucie Lafay-Cousin; Louis Letourneau; Mathieu Bourgey; Man Yu; Deena M A Gendoo; Misko Dzamba; Mark Barszczyk; Tiago Medina; Alexandra N Riemenschneider; A Sorana Morrissy; Young-Shin Ra; Vijay Ramaswamy; Marc Remke; Christopher P Dunham; Stephen Yip; Ho-Keung Ng; Jian-Qiang Lu; Vivek Mehta; Steffen Albrecht; Jose Pimentel; Jennifer A Chan; Gino R Somers; Claudia C Faria; Lucia Roque; Maryam Fouladi; Lindsey M Hoffman; Andrew S Moore; Yin Wang; Seung Ah Choi; Jordan R Hansford; Daniel Catchpoole; Diane K Birks; Nicholas K Foreman; Doug Strother; Almos Klekner; Laszló Bognár; Miklós Garami; Péter Hauser; Tibor Hortobágyi; Beverly Wilson; Juliette Hukin; Anne-Sophie Carret; Timothy E Van Meter; Eugene I Hwang; Amar Gajjar; Shih-Hwa Chiou; Hideo Nakamura; Helen Toledano; Iris Fried; Daniel Fults; Takafumi Wataya; Chris Fryer; David D Eisenstat; Katrin Scheinemann; Adam J Fleming; Donna L Johnston; Jean Michaud; Shayna Zelcer; Robert Hammond; Samina Afzal; David A Ramsay; Nongnuch Sirachainan; Suradej Hongeng; Noppadol Larbcharoensub; Richard G Grundy; Rishi R Lulla; Jason R Fangusaro; Harriet Druker; Ute Bartels; Ronald Grant; David Malkin; C Jane McGlade; Theodore Nicolaides; Tarik Tihan; Joanna Phillips; Jacek Majewski; Alexandre Montpetit; Guillaume Bourque; Gary D Bader; Alyssa T Reddy; G Yancey Gillespie; Monika Warmuth-Metz; Stefan Rutkowski; Uri Tabori; Mathieu Lupien; Michael Brudno; Ulrich Schüller; Torsten Pietsch; Alexander R Judkins; Cynthia E Hawkins; Eric Bouffet; Seung-Ki Kim; Peter B Dirks; Michael D Taylor; Anat Erdreich-Epstein; Cheryl H Arrowsmith; Daniel D De Carvalho; James T Rutka; Nada Jabado; Annie Huang
Journal:  Cancer Cell       Date:  2016-12-12       Impact factor: 31.743
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.